Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000887489 | SCV001031046 | likely benign | Tuberous sclerosis 1 | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001014984 | SCV001175763 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000887489 | SCV002040392 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003432878 | SCV004156642 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | TSC1: BP4, BP7 |
All of Us Research Program, |
RCV004003143 | SCV004819901 | likely benign | Tuberous sclerosis syndrome | 2023-05-16 | criteria provided, single submitter | clinical testing |